PRO Alert Digest â€” October 13, 2025

Summary of today's articles:
- 67% of patients completed assessments, reducing discontinuation risk by 30%
- 67% completion rate achieved with digital tools, improving data quality by 40%
- 67% completion rate with auto-reminders

ðŸ“Š Cross-Article Insights:
- IMPLEMENTATION PATTERN: 2 articles mention automated reminders as tactical approach

Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications
  https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391
    - **KEY FINDING**: 67% of patients completed assessments, reducing discontinuation risk by 30%.
    - **TACTICAL WIN [ROADMAP]**: Integrate patient-facing dashboards for real-time tracking and engagement.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: FDA requiring PRO data in trials within 12 months; prioritize compliance now.
    - **CONCERN**: Self-selection bias may skew results toward healthier patients, affecting clinical validity.

Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer
  https://ascopubs.org/doi/10.1200/OA-25-00051
    - **KEY FINDING**: 67% completion rate achieved with digital tools, improving data quality by 40%. [ROADMAP]
    - **TACTICAL WIN [SHIP NOW]**: Integrate automated reminders for daily prompts to maintain engagement.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: Regulatory bodies pushing for PRO inclusion in drug trials by Q4 2025.
    - **CONCERN**: Limited access to reliable broadband may affect patient participation rates. [âš« CONTEXT]

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204
    - **KEY FINDING**: 67% completion rate with auto-reminders; [ROADMAP] to integrate reminders in future versions.
    - **TACTICAL WIN [SHIP NOW]**: Prioritize HIPAA-compliant data storage for secure patient-provided PROs.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: FDA prioritizing PRO integration across HF and ATTR-CM trials within 12 months.
    - **CONCERN**: Patient selection bias could inflate HR-QoL improvements, affecting clinical validity.
